Search | Dengue Academy

Dengue Academy is intended for an international audience of healthcare professionals outside of the US and UK.
This website has been initiated and developed by Takeda

© Copyright 2022 Takeda Pharmaceutical Company Limited. All rights reserved.
Takeda and the Takeda Logo are registered trademarks of Takeda Pharmaceutical Company Limited.
VV-MEDMAT-55340, Date of preparation: November 2021

Dengue and post-infection fatigue: findings from a prospective cohort study

Takeda

2 minutes
Insecticide resistance in dengue vectors from hotspots in Selangor, Malaysia

Takeda

2 minutes
Similarities and differences between 'cytokine storms’ in acute dengue and COVID-19

Takeda

2 minutes
Impact of SARS-CoV-2 interventions on dengue transmission

Takeda

2 minutes
Dengue Vectors

Takeda

5 minutes
Vector control

Takeda

4 minutes
Case presentations in severe dengue: contemporary approaches to clinical management

Medscape

45 minutes
Managing the severely ill dengue patients – Adult and Paediatric Intensivists

ADVA

92 minutes
The COVID-19 pandemic should not jeopardize dengue control

Takeda

2 minutes
Zika and dengue but not chikungunya are associated with Guillain–Barré syndrome in Mexico: A case-control study

Takeda

2 minutes

Dengue Academy is intended for an international audience of healthcare professionals outside of the US and UK.
This website has been initiated and developed by Takeda